论文部分内容阅读
Polymer-drug conjugates,a novel nanoscale drug delivery system,have achieved fantastic developments over the decades[1].However,the clinical efficacy were always severely hampered by lack of tumor selectivity,inefficient drug delivery and low tolerability[2].